Sotabase

Career

· Equality Diversity And Inclusion, British Council2024–
· EDI Consultant, Retentionomics2023–2025
· MSc Education Dissertation Supervisor, The University of Edinburgh2020–2022
· Volunteer Teacher, British Red Cross2019–2022
· Equality, Diversity And Inclusion Consultant, University and College Union (UCU)2019–2024
· Teaching Fellow And EDI, University of Strathclyde2017–2024

Publications (16)

Modulators in concert for cognition: Modulator interactions in the prefrontal cortex
Progress in neurobiology · 2007
214
cited
Reduction of Brain Kynurenic Acid Improves Cognitive Function
Journal of Neuroscience · 2014
158
cited
Toward a Neuro-Cognitive Animal Model of the Cognitive Symptoms of Schizophrenia: Disruption of Cortical Cholinergic Neurotransmission Following Repeated Amphetamine Exposure in Attentional Task-Performing, but Not Non-Performing, Rats
Neuropsychopharmacology · 2007
55
cited
A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats
Neuropharmacology · 2014
49
cited
Nicotinic receptor subtypes differentially modulate glutamate release in the dorsal medial striatum
Neurochemistry International · 2016
26
cited
D1 agonist improved movement of parkinsonian nonhuman primates with limited dyskinesia side effects.
ACS Chemical Neuroscience · 2020
22
cited
In Vivo Modulation of Hippocampal Excitability by M4 Muscarinic Acetylcholine Receptor Activator: Implications for Treatment of Alzheimer's Disease and Schizophrenic Patients.
ACS Chemical Neuroscience · 2018
21
cited
Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine
Brain Research · 2006
19
cited
Clozapine-induced dopamine release in the medial prefrontal cortex is augmented by a moderate concentration of locally administered tyrosine but attenuated by high tyrosine concentrations or by tyrosine depletion
Psychopharmacology · 2005
15
cited
Cross-site strain comparison of pharmacological deficits in the touchscreen visual discrimination test
Psychopharmacology · 2015
13
cited
MAM (E17) rodent developmental model of neuropsychiatric disease: disruptions in learning and dysregulation of nucleus accumbens dopamine release, but spared executive function
Psychopharmacology · 2015
10
cited
α5 nAChR modulation of the prefrontal cortex makes attention resilient
Brain Structure and Function · 2018
9
cited
FUNCTIONAL AND PHARMACOLOGICAL CHARACTERIZATION OF A NOVEL AND SELECTIVE MUSCARINIC ACETYLCHOLINE M4 RECEPTOR ACTIVATOR
Alzheimer's & Dementia · 2017
5
cited
The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey
Frontiers in Aging Neuroscience · 2021
2
cited
2.14α5 nAChR modulation of the effects of nicotine on ventral-striatal DA release and cue-reward learning
2015
a Model Of Cognitive Dysfunction: Constrained Demands On Cholinergic Transmission And Attentional Capacities In Cht + /− Mice : Op03-06
2009
Sotabase
Damon Young | Researcher Profile | Sotabase | Sotabase